Peer-reviewedCC BYDiagnostics (Basel, Switzerland)
Quantitative Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Perfusion in Multiparametric Prostate MRI: An Exploratory Intra-Patient Study Differentiating Malignant Lesions from Normal Tissue
Related
- Multiparametric MRI-based radiomics for differentiating HER2-negative, HER2-low, and HER2-positive breast cancer
- Diagnostic Accuracy of Multiparametric Ultrasound Versus Cross-Sectional Imaging for Differentiating Benign and Malignant Cervical Lymph Nodes: A Histopathology-Referenced Retrospective Study
- Vascular habitat analysis using dynamic susceptibility contrast-enhanced perfusion MRI for differentiating glioblastoma from solitary brain metastases.
- Relative CT Number as a Quantitative Imaging Biomarker for Differentiating Sinonasal Polyp, Inverted Papilloma, and Squamous Cell Carcinoma: A Preliminary Retrospective Study
- Efficacy of arterial spin labeling magnetic resonance perfusion in differentiating recurrent or residual high-grade glioma from post-treatment changes: A retrospective hospital-based study.
BibTeX
@article{anon2026quantitative,
title = {{Quantitative Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Perfusion in Multiparametric Prostate MRI: An Exploratory Intra-Patient Study Differentiating Malignant Lesions from Normal Tissue}},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13663999},
note = {CC BY},
}
RIS
TY - JOUR
TI - Quantitative Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Perfusion in Multiparametric Prostate MRI: An Exploratory Intra-Patient Study Differentiating Malignant Lesions from Normal Tissue
PY - 2026
DA - 2026/09/22
JO - Diagnostics (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13663999
SN - 2075-4418
ER -